The Tamil Nadu government has banned the sale of the cough syrup ‘Coldrif’ following suspicions that it may be linked to the deaths of 11 children in Madhya Pradesh and Rajasthan. The directive, effective from October 1, mandates the removal of the syrup from all markets across the state, according to an official from the Food Safety and Drug Administration (FDA) Department.
If you enjoyed reading this article, you can help support our journalism by adding OHeraldo as a preferred source.
Authorities conducted inspections at the pharmaceutical company’s manufacturing facility in Sunguvarchathram, Kancheepuram district, over the past two days, collecting samples for testing. The city-based firm produces and supplies the medicine to states including Rajasthan, Madhya Pradesh, and the Union Territory of Puducherry.
The FDA has urged the public and pharmacies to comply with the ban immediately and to report any remaining stocks of the cough syrup. Investigations are ongoing to determine the cause of the suspected link to the child fatalities.
(This story is published from a syndicated feed)
